日本腎臓学会誌
Online ISSN : 1884-0728
Print ISSN : 0385-2385
ISSN-L : 0385-2385
ラットの半月体タイプ抗GBM腎炎に対する新angiotensin I変換酵素阻害剤,SA446[2R4R]-2-(o-hydroxypenyl)-3-(3-mercaptopropionyl)-4-thialzolidinecarboxylic acidの抗腎炎効果
鈴木 良雄伊藤 幹雄山田 久陽斎藤 直人筑紫 義仁
著者情報
ジャーナル フリー

1985 年 27 巻 11 号 p. 1485-1493

詳細
抄録

The present study was made to investigate the antinephritic effect of SA-446, an angiotensin I converting enzyme inhibitor, on the crescentic-type anti-glomerular basement membrane (anti-GBM) nephritis in rats. The nephritis was induced in male Sprague-Dawley rats weighing approx. 190 g by immunizing with rabbit r-globulin in Freund's complete adjuvant following i. v. injection of anti-GBM serum. SA-446 at doses of 5 and 25 mg/kg was given daily orally to rats from the day after injection of anti.GBM serum(the 1st day) to the 39 th day. SA-446 at doses of 5 and 25 mg/kg showed a tendency to reduce urinary protein excretion on the 12th and the 40th days and plasma choresterol level on the 40th day. In light microscopic observation of renal glomeruli on the 40th day, this drug at both doses remarkably prevented crescent formation, adhesion of capillary walls to Bowman's capsule and f ibrinoid degeneration. In addition, this drug at both doses also caused antihypertensive action from the 5 th day onwards. A highly significant positive correlation was recognized between blood pressure and crescent formation on the 40th day. It is concluded from these results that SA. 446 shows a beneficial action on the crescentic-type anti-GBM nephritis and may exert its action partly through lowing of blood pressure.

著者関連情報
© 社団法人日本腎臓学会
前の記事 次の記事
feedback
Top